GENTLEMACS
LIVE

Serial Number

79361531

Owner

MILTENYI BIOTEC B.V. & CO. KG

Attorney

Peter S. Sloane

Filing Date

Sep 12, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GENTLEMACS Trademark

Serial Number: 79361531 • Registration: 7232795

GENTLEMACS is a trademark filed by MILTENYI BIOTEC B.V. & CO. KG on September 12, 2022. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MILTENYI BIOTEC B.V. & CO. KG (38 trademarks)

BERGISCH GLADBACH 51429 , DE

Entity Type: 30

Trademark Details

Filing Date

September 12, 2022

Registration Date

December 5, 2023

Published for Opposition

September 19, 2023

Goods & Services

Scientific, optical and measuring apparatus and instruments, namely, laboratory apparatus and instruments for the fragmentation, separation, analysis, processing and cultivation of biological material; apparatus for recording, transmission or reproduction of images; data processing equipment; downloadable computer software, for use in operating and controlling equipment in connection with the separation, analysis, processing and cultivation of biological material; scientific, laboratory apparatus being electrical and electronic apparatus and instruments for conducting enzymatic reactions; laboratory equipment, in particular cytometer for measuring physical and chemical properties of cells and other particles in suspensions; laboratory equipment being tissue fragmentation machines for research use, namely, for use in pathology; laboratory equipment being tissue fragmentation vessels for research use; laboratory equipment, being sacks, bags, sheets, tubes and connectors for scientific or biotechnological purposes, in particular for tissue fragmentation for use in cryopreservation; laboratory apparatus and instruments for scientific purposes, namely, tissue fragmentation equipment

Chemical, biological and biochemical products for industrial, scientific and diagnostic purposes, other than for medical or veterinary use, namely, biological tissue cultures, diagnostic preparations for scientific use, enzymes and lysing reagent for tissue fragmentation; chemical preparations for use in separation processes for biological materials; reagents for scientific research and use, namely, reagents for cell separation or cell fragmentation, labeling reagents, and reagents for the preparation of media, all for commercial and scientific purposes and for the use in medical research laboratories; chemical reagents, not for medical or veterinary purposes, for the fragmentation, processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of chemical and biological materials; chemical reagents with magnetic beads; chemical antibody reagents, other than for medical or veterinary purposes; buffer solutions and chemical reagents for use with laboratory instruments, especially fragmentation or separation instruments, chemical analysis instruments, reactors and imaging instruments; reagents other than for medical or veterinary purposes, for processing of biological material, especially tissue, bone marrow, cells, blood and its components; diagnostic reagents and preparations for scientific purposes and for use in medical research laboratories; cell culture media for in-vivo imaging, all for scientific purposes; chemical reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry

Medical apparatus for magnetic cell separation for medical purposes; blood tubing sets, sold empty, for medical purposes; medical apparatus being columns for analysis for medical purposes; sacks, bags, sheets, tubes and connectors for medical purposes, in particular for tissue and blood collection for cryopreservation; tissue fragmentation machines for medical use, namely, machines for use in pathology; tissue fragmentation vessels being test tubes for medical use; medical apparatus and instruments, namely, tissue fragmentation equipment

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 2, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 7, 2024 FICS
FINAL DISPOSITION PROCESSED
Mar 6, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 5, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 5, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 5, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 19, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Sep 18, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 30, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 30, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 30, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 15, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 15, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 15, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 15, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 10, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 7, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 7, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 7, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 7, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 7, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 7, 2023 COAR
REFUSAL PROCESSED BY IB
Aug 1, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 7, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jul 6, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 23, 2023 RFCR
NON-FINAL ACTION WRITTEN
May 22, 2023 CNRT
ASSIGNED TO EXAMINER
May 16, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 2, 2023 REPR